908 DEVICES INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
908 DEVICES INC. (MASS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- 908 DEVICES INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.31M, a 0.98% decline year-over-year.
- 908 DEVICES INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.40M, a 1.44% increase year-over-year.
- 908 DEVICES INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $2.38M, a 25.63% decline year-over-year.
- 908 DEVICES INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $2.34M, a 24.55% decline year-over-year.
- 908 DEVICES INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $9.85M, a 16.31% decline from fiscal 2024.
- 908 DEVICES INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $11.76M, a 20.19% increase from fiscal 2023.
- 908 DEVICES INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $9.79M, a 35.80% increase from fiscal 2022.
- 908 DEVICES INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $7.21M, a 187.82% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.31M 10-Q · filed 2026-08-11 | $4.71M derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $2.40M 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $9.85M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $2.38M 10-Q · filed 2025-11-10 | $4.71M derived: sum of 2 quarters · filed 2026-08-11 | $7.08M derived: sum of 3 quarters · filed 2026-08-11 | |
| 2025-06-30 | $2.34M 10-Q · filed 2026-08-11 | $4.70M derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $2.37M 10-Q · filed 2026-08-11 | |||
| 2024-12-31 | $11.76M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $3.20M 10-Q · filed 2025-11-10 | $6.29M derived: sum of 2 quarters · filed 2025-11-10 | $8.94M derived: sum of 3 quarters · filed 2025-11-10 | |
| 2024-06-30 | $3.10M 10-Q · filed 2025-11-10 | $5.74M derived: sum of 2 quarters · filed 2025-11-10 | ||
| 2024-03-31 | $2.64M 10-Q · filed 2025-11-10 | |||
| 2023-12-31 | $9.79M 10-K · filed 2025-03-07 | |||
| 2023-09-30 | $2.70M 10-Q · filed 2024-11-12 | $5.28M derived: sum of 2 quarters · filed 2024-11-12 | $7.45M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $2.58M 10-Q · filed 2024-11-12 | $4.74M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $2.17M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $7.21M 10-K · filed 2024-03-08 | |||
| 2022-09-30 | $2.02M 10-Q · filed 2023-11-07 | $3.91M derived: sum of 2 quarters · filed 2023-11-07 | $5.20M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | $1.89M 10-Q · filed 2023-11-07 | $3.18M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | $1.29M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $2.50M 10-K · filed 2023-03-15 | |||
| 2021-09-30 | $811.00K 10-Q · filed 2022-11-14 | $1.29M derived: sum of 2 quarters · filed 2022-11-14 | $1.63M derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | $481.00K 10-Q · filed 2022-11-14 | $820.00K derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2021-03-31 | $339.00K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $525.00K 10-K · filed 2022-03-11 | |||
| 2020-09-30 | $83.00K 10-Q · filed 2021-11-04 | $152.00K derived: sum of 2 quarters · filed 2021-11-04 | $218.00K derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $69.00K 10-Q · filed 2021-11-04 | $135.00K derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $66.00K 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |